Skip to content
P Pitch Archive Stock pitches across investing competitions
← Winter 2016

Quest Diagnostics

DGX pitch short Nielsen Fields ’17, Joanna Vu ’17, and Adam Xiao ’17

Thesis

Quest Diagnostics is expected to struggle due to regulatory pressures and a challenging reimbursement environment, which could negatively impact its profitability and stock performance.

Did it work?

inconclusive confidence: low

The pitch is a short thesis resting on vague expectations of regulatory pressure and reimbursement headwinds, but no price performance and no elapsed time are provided, and the thesis cites no specific catalysts or timeline that could be checked against known events. Without either a return figure or confirmation that the predicted profitability deterioration actually occurred, there is no basis to judge the thesis as played out or broken.